TY - JOUR
T1 - Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy
AU - Deura, Imari
AU - Shimada, Muneaki
AU - Hirashita, Keiko
AU - Sugimura, Maki
AU - Sato, Seiya
AU - Sato, Shinya
AU - Oishi, Tetsuro
AU - Itamochi, Hiroaki
AU - Harada, Tasuku
AU - Kigawa, Junzo
N1 - Publisher Copyright:
© 2014, Japan Society of Clinical Oncology.
PY - 2015/6/11
Y1 - 2015/6/11
N2 - Background: Lower limb lymphedema (LLL) is one of the most frequent postoperative complications of retroperitoneal lymphadenectomy for gynecologic cancer. LLL often impairs quality of life, activities of daily living, sleep, and sex in patients with gynecologic cancer. We conducted this study to evaluate the incidence and risk factors for LLL after gynecologic cancer surgery in patients who received assessment and periodic complex decongestive physiotherapy (CDP). Methods: We retrospectively reviewed 126 cases of gynecologic cancer that underwent surgery involving retroperitoneal lymphadenectomy at Tottori University Hospital between 2009 and 2012. All patients received physical examinations to detect LLL and underwent CDP by nurse specialists within several months after surgery. The International Society of Lymphology staging of lymphedema severity was used as the diagnostic criteria. Results: Of 126 patients, 57 (45.2 %) had LLL, comprising 45 and 12 patients with stage 1 and stage 2 LLL, respectively. No patient had stage 3 LLL. LLL was present in 37 (29.4 %) patients at the initial physical examination. Multivariate analysis revealed that adjuvant concurrent chemoradiotherapy and age ≥55 years were independent risk factors for ≥stage 2 LLL. Conclusions: To minimize the incidence of ≥stage 2 LLL, gynecologic oncologists should be vigilant for this condition in patients who are ≥55 years and in those who undergo adjuvant chemoradiotherapy. Patients should be advised to have a physical assessment for LLL and to receive education about CDP immediately after surgery involving retroperitoneal lymphadenectomy for gynecologic cancer.
AB - Background: Lower limb lymphedema (LLL) is one of the most frequent postoperative complications of retroperitoneal lymphadenectomy for gynecologic cancer. LLL often impairs quality of life, activities of daily living, sleep, and sex in patients with gynecologic cancer. We conducted this study to evaluate the incidence and risk factors for LLL after gynecologic cancer surgery in patients who received assessment and periodic complex decongestive physiotherapy (CDP). Methods: We retrospectively reviewed 126 cases of gynecologic cancer that underwent surgery involving retroperitoneal lymphadenectomy at Tottori University Hospital between 2009 and 2012. All patients received physical examinations to detect LLL and underwent CDP by nurse specialists within several months after surgery. The International Society of Lymphology staging of lymphedema severity was used as the diagnostic criteria. Results: Of 126 patients, 57 (45.2 %) had LLL, comprising 45 and 12 patients with stage 1 and stage 2 LLL, respectively. No patient had stage 3 LLL. LLL was present in 37 (29.4 %) patients at the initial physical examination. Multivariate analysis revealed that adjuvant concurrent chemoradiotherapy and age ≥55 years were independent risk factors for ≥stage 2 LLL. Conclusions: To minimize the incidence of ≥stage 2 LLL, gynecologic oncologists should be vigilant for this condition in patients who are ≥55 years and in those who undergo adjuvant chemoradiotherapy. Patients should be advised to have a physical assessment for LLL and to receive education about CDP immediately after surgery involving retroperitoneal lymphadenectomy for gynecologic cancer.
KW - Complex decongestive physiotherapy
KW - Gynecologic cancer
KW - Lower limb lymphedema
KW - Lymphadenectomy
UR - http://www.scopus.com/inward/record.url?scp=84930649469&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930649469&partnerID=8YFLogxK
U2 - 10.1007/s10147-014-0724-0
DO - 10.1007/s10147-014-0724-0
M3 - Article
C2 - 24993674
AN - SCOPUS:84930649469
SN - 1341-9625
VL - 20
SP - 556
EP - 560
JO - International Journal of Clinical Oncology
JF - International Journal of Clinical Oncology
IS - 3
ER -